Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Pancreatic and biliary tract cancer are ones of the leading causes of cancer-related deaths. During the course of illness, these patients often experience marked physical suffering, psychological distress and frequent unplanned resource-demanding hospitalized care. Patients with pancreatic and lung cancer have highest rates of unplanned hospitalizations. Investigator initiated prospective "Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)" is to be initiated based on the great need for optimizing treatment care, reducing hospitalizations and improving outcomes.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek co najmniej 18 lat
  • •Potwierdzony zaawansowany rak trzustki, dróg żółciowych lub płuc
  • •Pisemna zgoda na udział w badaniu
  • •Planowana chemioterapia w ciągu 2 tygodni
  • •Dostęp do internetu i urządzenia mobilnego
  • •Możliwość samodzielnego lub z małą pomocą wypełniania ankiet

✗ Disqualifies

  • •Brak urządzenia mobilnego (smartfon, tablet)
  • •Poważne problemy psychiatryczne lub zaburzenia pamięci
  • •Inne warunki zdrowotne mogące zagrażać bezpieczeństwu
  • •Jednoczesny udział w innym badaniu klinicznym mogącym interferować z tym badaniem

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
September 2, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

Herlev & Gentofte University Hospital, Denmark

Herlev, Denmark

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/3/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.